Shorts

0:44
Savitha Krishnan, MD, on signs of prolapse urologists should watch for
a day ago
by
Savitha Krishnan, MD

0:20
Zach Feuer, MD, on the impact of wait times for prostate biopsy referral
2 days ago
by
Zach Feuer, MD

1:19
María Natalia Gandur Quiroga, MD, MSc, discusses the evolution of immunotherapy in bladder cancer
3 days ago
by
María Natalia Gandur Quiroga, MD, MSc

0:39
Matthew Nielsen, MD, MS, FACS, shares what he’s looking forward to at AUA 2026
4 days ago
by
Matthew Nielsen, MD, MS, FACS

0:53
Amy E. Krambeck, MD, discusses the most common morcellation error in practice
7 days ago
by
Amy E. Krambeck, MD

0:42
Jihad Kaouk, MD, on innovation in patient care at Cleveland Clinic
8 days ago
by
Jihad Kaouk, MD, FACS, FRCS (G)

1:04
María Natalia Gandur Quiroga, MD, MSc, on the most important recent advance in bladder cancer
9 days ago
by
María Natalia Gandur Quiroga, MD, MSc

0:24
Ramy Abou Ghayda, MD, MPH, on the UH Cutler Center for Men
10 days ago
by
Ramy Abou Ghayda, MD, MPH

1:01
Pedro-José López, MD, on discussing bladder exstrophy with parents
11 days ago
by
Pedro-José López, MD

0:32
Jihad Kaouk, MD, on getting started with single-port surgery
14 days ago
by
Jihad Kaouk, MD, FACS, FRCS (G)

0:41
Christopher Weight, MD, MS, on determining candidates for bladder preservation
15 days ago
by
Christopher Weight, MD, MS

0:33
Petar Bajic, MD, on when physicians should refer patients with Peyronie disease
16 days ago
by
Petar Bajic, MD

0:51
J. Welles Henderson, MD, FACOG, on managing mixed urinary incontinence
17 days ago
by
J. Welles Henderson, MD, FACOG

0:44
David Wise, MD, on the efficacy of pasritamig plus docetaxel in mCRPC
18 days ago
by
David R. Wise, MD, PhD

1:34
Amy E. Krambeck, MD, on 3- vs 2-lobe enucleation for BPH
22 days ago
by
Amy E. Krambeck, MD

0:20
Mohit Khera, MD, MBA, MPH, on why FDA TRT announcement is a “big win”
23 days ago
by
Mohit Khera, MD, MBA, MPH

1:01
The UroOnc Minute: Dr. Alfonso Gómez de Liaño Lista on implications of KEYNOTE-B15
24 days ago
by
Adam B. Weiner, MD(+1 more)

0:21
Jesse N. Mills, MD, on why urologists need to be at the forefront of treating low libido
25 days ago
by
Jesse N. Mills, MD

1:28
Landon Trost, MD, on the significance of the FDA announcement on idiopathic hypogonadism
a month ago
by
Landon W. Trost, MD

0:43
Mohit Khera, MD, MBA, MPH, reacts to FDA announcement on TRT and idiopathic hypogonadism
a month ago
by
Mohit Khera, MD, MBA, MPH

1:01
The Expert APProach: Melissa Kestler, DNP, FNP-BC, on working in a stone clinic
a month ago
by
Joy Maulik, CRNP(+1 more)

0:51
James R. Porter, MD, on the telementoring capabilities of the Hugo RAS
a month ago
by
James R. Porter, MD

1:12
Pearls & Perspectives: Normalizing sexual wellness conversations
a month ago
by
Amy M. Pearlman, MD

1:13
Jennifer Miles-Thomas, MD, discusses areas of opportunity for urology APPs
a month ago
by
Jennifer Miles-Thomas, MD, URPS, MBA

0:59
The Expert APProach: Preparing the Next Generation of APPs
a month ago
by
Joy Maulik, CRNP(+1 more)

1:03
Akanksha Mehta, MD, on counseling men on vasectomy safety
a month ago
by
Akanksha Mehta, MD, MS(+1 more)

1:10
Jonathan Anker, MD, on bladder-sparing approach in patients with MIBC
a month ago
by
Jonathan F. Anker, MD, PhD

1:15
Daniel J. George, MD, on PTEN loss and prostate cancer prognosis
a month ago
by
Daniel J. George, MD

1:02
Alexandra Drakaki, MD, on misdiagnosis of bladder cancer in women
a month ago
by
Alexandra Drakaki, MD, PhD

1:02
Pearls & Perspectives: What is “normal” urination frequency?
a month ago
by
Amy M. Pearlman, MD
Advertisement
Advertisement
Trending on Urology Times
1
AUA 2026 preview: Practice-changing trials in urologic oncology
2
Perioperative durvalumab plus enfortumab vedotin improves EFS in cisplatin-ineligible MIBC
3
AUA 2026 preview: Practice-changing trials in benign urology
4
Matthew Nielsen, MD, MS, FACS, previews key themes at the 2026 AUA Annual Meeting
5
